Ritu Verma of Ankur Capital discusses what is required for Indian healthtech and digital diagnostic startups to reach billion-dollar valuations.
Prediction Not checkable as stated
Verma: India is a sandbox for developing globally exported, world-class agritech
“Agriculture is a global play, and I always think that India, and this has been played out in other industries, is the, is a really great sandbox where, you know, we have really good tech talent, That not much money develops world-class products, and that's app…”
Disclosure
Verma: Ankur Capital is sector-agnostic but strictly targets mass-market Indian consumers
“So we are sector agnostic Siddharth We are, but we are market, not market agnostic necessarily. We're looking for solutions that can actually unlock these larger markets, as I said earlier.”
Insight
Verma: Physical-world tech adoption scales slower but creates far stronger defensive moats
“There is an intersection of these technologies with the physical world, which obviously slows things down, you know, versus something going viral in a year or two. Ah, but on the other hand, these are modes, right? So as you get those right, ah, dislodging you…”
Assertion Partly supported
Verma: India's agricultural inputs market is a 70,000 crore rupee industry
“One is in imports and agri inputs and how that kind of goes in. It's again a 50,000 crore or 70,000 crore kind of industry.”
Assertion Not checkable as stated
Verma: Cropin retained its earliest enterprise customers and expanded their contract sizes
“Their first customers are still customers. As a matter of fact, not at the same size, but at much larger sizes.”
Disclosure
Verma: Ankur Capital has expanded its check sizes up to $5 million
“We used to do about a million dollar checks. We can now go up to five million dollars.”